Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

People line up to vote at Highbury Shopping Center in Auckland, New ealand, on Saturday. Photo: Rebecca Falconer/Axios

AUCKLAND, New Zealand — National polls opened for early voting on Saturday for what Prime Minister Jacinda Ardern has called the "Covid election."

Driving the news: NZ quashed the virus after one of the world's toughest lockdowns and went 102 days with no detected cases before COVID-19 re-emerged. There are now seven active domestic cases.

A voter casts her referendum ballot before dropping her vote for her selected party and election candidate into the orange box. New Zealanders are voting on whether to legalize cannabis and on the End of Life Choice assisted dying bill. Photo: Rebecca Falconer/Axios
  • Shaun Hendy, a leading scientist who heads Te Pūnaha Matatini, a research center advising the government, told Axios, "We think there’s a really high chance it has died out in the community."
"Although we’ve still got cases in isolation quarantine, we think there’s a 95% chance there are no more community cases out there."
— Shaun Hendy

The big picture: Ardern's Labour Party is ahead in the polls of its nearest rival, the right-leaning National Party, led by Judith Collins, though Labour's lead has shrunk in recent weeks. The election was delayed by four weeks to Oct. 17 because of the second outbreak.

For the record: New Zealand's most populous city, Auckland, went into level 3 restrictions under the country's four-tier system, with non-essential businesses allowed to open as long as there were no physical interactions with customers.

  • The rest of NZ moved to level 2, with table service required in bars, social distancing reintroduced and gatherings limited. Wearing face masks is mandatory on public transport. Auckland's restrictions were later eased.
  • Authorities contained the cluster and there are no domestic restrictions in place outside Auckland as there is no community spread. Hendy credits quickly deploying Auckland's second lockdown and improved contact-tracing systems. He1 expects them to lift next week.

Of note: A New Zealand Electoral Commission spokesperson said voting will operate nationally as if there were community spread, with precautions such as social distancing, use of hand sanitizer and single-use pens to mark ballots.

  • NZ has had advance voting for years, available as an automatic choice since 2011. But this year as a pandemic safety measure the commission extended early voting by two days and added "more voting places, to keep queues to a minimum," the spokesperson said via email.

Threat level: NZ's borders have been closed to all non-residents since March, but they've remained open to returning Kiwis. 42 such travelers have the coronavirus and are in quarantine centers.

  • Among them are 10 people who traveled on the same plane from India, NZ Public Health Director Caroline McElnay said Thursday, the last time any new cases were announced.
  • Hendy said this shows the effectiveness of the quarantine and rigorous testing.

The bottom line: "The key to avoiding a lockdown in future is catching it early, and that means keeping our testing rates up," per Hendy.

Go deeper: Australia and New Zealand to open "safe travel zone"

Editor's note: This article has been updated with the latest number of active community cases.

Go deeper

Jan 5, 2021 - World

Israel tightens COVID-19 lockdown restrictions

Despite launching one of the most successful vaccination campaigns in the world, Israel has had to counter a spike in new COVID cases in recent weeks. Photo: Jack Guez/AFP via Getty

Israel will impose new restrictions in its countrywide lockdown, closing schools and nonessential businesses beginning Friday to combat surging cases of the coronavirus, government ministers voted Tuesday.

The big picture: Israel’s COVID-19 cases, which dropped in October, have jumped to more than 5,000 reported daily in the new year, Johns Hopkins University data shows. Prime Minister Benjamin Netanyahu called on the public Tuesday to heed new restrictions as a faster-spreading variant of the virus first detected in the U.K. multiplies.

Alabama's new congressional map rejected by federal judges

The Alabama State Capitol in Montgomery. Photo: Taylor Hill/Getty Images

Federal judges on Monday night blocked Alabama's newly drawn congressional map and ordered the Republican-led State Legislature to create a new one that includes two districts, rather than the planned one.

Why it matters: "Black voters have less opportunity than other Alabamians to elect candidates of their choice to Congress," the panel of three judges wrote in their ruling.

FDA limits use of Regeneron and Lilly COVID antibody treatments

A coldbox containing monoclonal antibody treatments at a Regeneron clinic in Pembroke Pines, Florida, in August. Photo: Eva Marie Uzcategui/Bloomberg via Getty Images

The FDA said Monday it's limiting the use of two monoclonal antibody therapies as COVID-19 treatments because data indicates they're "highly unlikely" to be effective against the dominant Omicron variant.

Driving the news: The FDA revised the authorizations for Regeneron and Eli Lilly "to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments," per a statement from the agency.